-
Something wrong with this record ?
NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy
K. Kuricová, V. Tanhäuserová, L. Pácal, V. Bartáková, L. Brožová, J. Jarkovský, K. Kaňková,
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT11405
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2013
Free Medical Journals
from 2010
ProQuest Central
from 1994-05-01 to 1 year ago
Open Access Digital Library
from 2013-01-01
Medline Complete (EBSCOhost)
from 2005-01-01
Health & Medicine (ProQuest)
from 1994-05-01 to 1 year ago
Karger Open Access
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1996
PubMed
24603156
DOI
10.1159/000355757
Knihovny.cz E-resources
- MeSH
- Diabetes Mellitus, Type 2 enzymology genetics MeSH
- Diabetic Cardiomyopathies enzymology epidemiology genetics MeSH
- Diabetic Nephropathies enzymology epidemiology genetics MeSH
- Glomerular Filtration Rate MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Polymorphism, Genetic genetics MeSH
- Disease Progression MeSH
- Prospective Studies MeSH
- Aged MeSH
- Nitric Oxide Synthase Type III genetics MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND/AIMS: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. METHODS: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. RESULTS: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GT genotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 - 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 - 5.965], P = 0.036). CONCLUSION: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008222
- 003
- CZ-PrNML
- 005
- 20190611095505.0
- 007
- ta
- 008
- 150306s2013 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000355757 $2 doi
- 035 __
- $a (PubMed)24603156
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Chalásová, Katarína $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 mub2017949800
- 245 10
- $a NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy / $c K. Kuricová, V. Tanhäuserová, L. Pácal, V. Bartáková, L. Brožová, J. Jarkovský, K. Kaňková,
- 520 9_
- $a BACKGROUND/AIMS: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. METHODS: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. RESULTS: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GT genotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 - 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 - 5.965], P = 0.036). CONCLUSION: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a diabetes mellitus 2. typu $x enzymologie $x genetika $7 D003924
- 650 _2
- $a diabetická kardiomyopatie $x enzymologie $x epidemiologie $x genetika $7 D058065
- 650 _2
- $a diabetické nefropatie $x enzymologie $x epidemiologie $x genetika $7 D003928
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a synthasa oxidu dusnatého, typ III $x genetika $7 D052250
- 650 _2
- $a polymorfismus genetický $x genetika $7 D011110
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tanhäuserová, Veronika $7 _AN049374
- 700 1_
- $a Pácal, Lukáš $7 xx0084072
- 700 1_
- $a Bartáková, Vendula $7 xx0240193
- 700 1_
- $a Brožová, Lucie $7 xx0213022
- 700 1_
- $a Jarkovský, Jiří, $d 1976- $7 stk2008461294
- 700 1_
- $a Kaňková, Kateřina, $d 1971- $7 mzk2003190820
- 773 0_
- $w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 38, č. 1 (2013), s. 92-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24603156 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20190611095649 $b ABA008
- 999 __
- $a ok $b bmc $g 1065495 $s 891022
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 38 $c 1 $d 92-98 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
- GRA __
- $a NT11405 $p MZ0
- LZP __
- $a Pubmed-20150306